NO163618C - Analogifremgangsmaate for fremstilling av terapeutisk aktive aryloksy- og aryltio-hydroksypropyl-piperazin-acetanilider. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive aryloksy- og aryltio-hydroksypropyl-piperazin-acetanilider.Info
- Publication number
- NO163618C NO163618C NO841968A NO841968A NO163618C NO 163618 C NO163618 C NO 163618C NO 841968 A NO841968 A NO 841968A NO 841968 A NO841968 A NO 841968A NO 163618 C NO163618 C NO 163618C
- Authority
- NO
- Norway
- Prior art keywords
- lower alkyl
- independently hydrogen
- together form
- aryltio
- acetanilides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Cosmetics (AREA)
- Pyridine Compounds (AREA)
- Polyesters Or Polycarbonates (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/495,904 US4567264A (en) | 1983-05-18 | 1983-05-18 | Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry |
Publications (3)
Publication Number | Publication Date |
---|---|
NO841968L NO841968L (no) | 1984-11-19 |
NO163618B NO163618B (no) | 1990-03-19 |
NO163618C true NO163618C (no) | 1990-06-27 |
Family
ID=23970461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO841968A NO163618C (no) | 1983-05-18 | 1984-05-16 | Analogifremgangsmaate for fremstilling av terapeutisk aktive aryloksy- og aryltio-hydroksypropyl-piperazin-acetanilider. |
Country Status (26)
Country | Link |
---|---|
US (1) | US4567264A (no) |
EP (1) | EP0126449B1 (no) |
JP (1) | JPS59219271A (no) |
KR (1) | KR890000020B1 (no) |
AT (1) | ATE31533T1 (no) |
AU (1) | AU566489B2 (no) |
BR (1) | BR1100474A (no) |
CA (1) | CA1256874A (no) |
CS (1) | CS246080B2 (no) |
DE (1) | DE3468215D1 (no) |
DK (1) | DK168535B1 (no) |
ES (1) | ES532565A0 (no) |
FI (1) | FI78479C (no) |
HK (1) | HK91989A (no) |
HU (1) | HU192404B (no) |
IE (1) | IE57487B1 (no) |
IL (1) | IL71863A (no) |
MX (1) | MX9203001A (no) |
NO (1) | NO163618C (no) |
NZ (1) | NZ208188A (no) |
PH (1) | PH20016A (no) |
PL (2) | PL142760B1 (no) |
PT (1) | PT78604B (no) |
RU (2) | RU2071471C1 (no) |
SG (1) | SG25086G (no) |
ZA (1) | ZA843746B (no) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5028610A (en) * | 1987-03-18 | 1991-07-02 | Sankyo Company Limited | N-benzhydryl-substituted heterocyclic derivatives, their preparation and their use |
ATE102931T1 (de) * | 1988-12-26 | 1994-04-15 | Kowa Co | Herstellung von glycidylaether. |
EP0714660B1 (en) * | 1989-06-23 | 2002-09-04 | Syntex (U.S.A.) LLC | Ranolazine and related piperazines for protecting skeletal muscles |
HU209723B (en) * | 1990-10-31 | 1994-10-28 | Richter Gedeon Vegyeszet | Process for producing of piperazine derivatives |
US5455045A (en) * | 1993-05-13 | 1995-10-03 | Syntex (U.S.A.) Inc. | High dose formulations |
WO1996040664A2 (en) * | 1995-06-07 | 1996-12-19 | Dade Chemistry Systems Inc. | Preparation of immunogens and other conjugates of drugs |
US6303607B1 (en) * | 1998-09-10 | 2001-10-16 | Cv Therapeutics, Inc. | Method for administering a sustained release ranolanolazine formulation |
US6479496B1 (en) * | 1998-09-10 | 2002-11-12 | Cv Therapeutics, Inc. | Methods for treating angina with ranolazine |
MXPA02007639A (es) * | 2000-02-18 | 2004-08-23 | Cv Therapeutics Inc | Inhibidores de la oxidacion parcial de los acidos grasos en el tratamiento de la falla cardiaca congestiva. |
AU3862301A (en) * | 2000-02-22 | 2001-09-03 | Cv Therapeutics Inc | Substituted piperazine compounds |
US6451798B2 (en) * | 2000-02-22 | 2002-09-17 | Cv Therapeutics, Inc. | Substituted alkyl piperazine derivatives |
AU2001238590A1 (en) | 2000-02-22 | 2001-09-03 | Cv Therapeutics, Inc. | Substituted piperazine compounds |
WO2001062711A2 (en) * | 2000-02-22 | 2001-08-30 | Cv Therapeutics, Inc. | Substituted alkylene diamine compounds |
US6552023B2 (en) * | 2000-02-22 | 2003-04-22 | Cv Therapeutics, Inc. | Aralkyl substituted piperazine compounds |
US6677336B2 (en) * | 2000-02-22 | 2004-01-13 | Cv Therapeutics, Inc. | Substituted piperazine compounds |
WO2002007716A2 (en) * | 2000-07-21 | 2002-01-31 | Cv Therapeutics, Inc. | Method for treating angina |
WO2003079972A2 (en) | 2002-02-22 | 2003-10-02 | New River Parmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
US6693099B2 (en) * | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
US6573264B1 (en) | 2000-10-23 | 2003-06-03 | Cv Therapeutics, Inc. | Heteroaryl alkyl piperazine derivatives |
US7001909B2 (en) * | 2001-07-19 | 2006-02-21 | Cv Therapeutics, Inc. | Substituted heterocyclic compounds |
DE60203623T2 (de) * | 2001-07-19 | 2006-01-19 | CV Therapeutics, Inc., Palo Alto | Substituierte piperazinderivate und ihre verwendung als fettsaüre-oxidationsinhibitoren |
US20030220344A1 (en) | 2002-04-04 | 2003-11-27 | Luiz Belardinelli | Method of treating arrhythmias |
US20080109040A1 (en) * | 2002-04-04 | 2008-05-08 | Luiz Belardinelli | Method of treating arrhythmias |
US8822473B2 (en) * | 2002-05-21 | 2014-09-02 | Gilead Sciences, Inc. | Method of treating diabetes |
US20040063717A1 (en) | 2002-05-21 | 2004-04-01 | Andrew Wolff | Method of treating diabetes |
WO2004000824A1 (en) | 2002-06-24 | 2003-12-31 | Janssen Pharmaceutica N.V. | Process for the production of n-(2,6-dimethyl-phenyl)-2-piperazin-1-yl-acetamide |
US7056924B2 (en) * | 2002-07-18 | 2006-06-06 | Cv Therapeutics, Inc. | Substituted heterocyclic compounds |
EP1806346B1 (en) * | 2002-12-05 | 2009-07-22 | Cv Therapeutics, Inc. | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
AU2003300827B2 (en) * | 2002-12-05 | 2009-08-13 | Gilead Palo Alto, Inc. | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
WO2004063180A1 (en) * | 2003-01-03 | 2004-07-29 | Cv Therapeutics, Inc. | Substituted heterocyclic compounds |
KR20050092424A (ko) * | 2003-01-17 | 2005-09-21 | 씨브이 쎄러퓨틱스, 인코포레이티드 | 심혈관 질환의 치료에 유용한 치환된 헤테로고리 화합물 |
JP2007518677A (ja) * | 2003-06-23 | 2007-07-12 | シーブイ・セラピューティクス・インコーポレイテッド | 脂肪酸酸化インヒビターとしてのピペラジンおよびピペリジンのウレア誘導体 |
CA2550257A1 (en) | 2003-12-18 | 2005-07-07 | Cv Therapeutics, Inc. | 1-akan-2-ol substituted piperazine and piperidine compounds |
WO2006008753A1 (en) * | 2004-07-19 | 2006-01-26 | Unichem Laboratories Limited | Crystalline and amorphous form of ranolazine and the process for manufacturing them |
AU2005282492A1 (en) * | 2004-09-08 | 2006-03-16 | Gilead Palo Alto, Inc. | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
BRPI0606403A2 (pt) * | 2005-01-06 | 2009-06-23 | Cv Therapeutics Inc | formulações farmacêuticas com liberação sustentada e seus usos |
WO2008047388A2 (en) * | 2006-10-20 | 2008-04-24 | Ind-Swift Laboratories Limited | Improved process for the preparation of ranolazine |
JP2010518181A (ja) | 2007-02-13 | 2010-05-27 | ギリアード・パロ・アルト・インコーポレイテッド | 心血管疾患の処置のためのラノラジンの使用 |
EP2117549A1 (en) * | 2007-02-13 | 2009-11-18 | CV Therapeutics Inc. | Use of ranolazine for the treatment of coronary microvascular diseases |
US20090111826A1 (en) * | 2007-02-13 | 2009-04-30 | Louis Lange | Use of ranolazine for the treatment of cardiovascular diseases |
WO2008101012A1 (en) * | 2007-02-13 | 2008-08-21 | Cv Therapeutics, Inc. | Use of ranolazine for the treatment of non-coronary microvascular diseases |
WO2008109175A1 (en) * | 2007-03-07 | 2008-09-12 | Concert Pharmaceuticals, Inc. | Deuterated piperazine derivatives as anti-anginal compounds |
US20080233191A1 (en) * | 2007-03-22 | 2008-09-25 | Brent Blackburn | Use of ranolazine for elevated brain-type natriuretic peptide |
WO2008139492A2 (en) * | 2007-05-15 | 2008-11-20 | Natco Pharma Limited | A process for the preparation of highly pure ranolazine base |
KR20100033490A (ko) * | 2007-05-31 | 2010-03-30 | 질레드 팔로 알토 인코포레이티드 | 상승된 뇌-형 나트륨이뇨 펩티드에 대한 라놀라진 |
CN101835761A (zh) * | 2007-06-13 | 2010-09-15 | 奥斯拜客斯制药有限公司 | 取代的哌嗪 |
US20090247535A1 (en) * | 2008-03-26 | 2009-10-01 | Duke University | Use of ranolazine for non-cardiovascular disorders |
WO2009153651A1 (en) * | 2008-06-19 | 2009-12-23 | Medichem, S.A. | Process for preparing a piperazine derivative |
EP2328873A4 (en) * | 2008-08-28 | 2011-09-07 | Reddys Lab Ltd Dr | PREPARATION OF RANOLAZINE |
WO2010023687A2 (en) * | 2008-08-28 | 2010-03-04 | Shodhana Laboratories Limited | Preparation of ranolazine, its salts and intermediates thereof |
US20110300218A1 (en) * | 2008-09-09 | 2011-12-08 | Actavis Group Ptc Ehf | Novel solid state forms of ranolazine salts |
US20110223213A1 (en) * | 2008-10-15 | 2011-09-15 | Actavis Group Ptc Ehf | Highly pure ranolazine or a pharmaceutically acceptable salt thereof |
WO2010097805A1 (en) | 2009-02-24 | 2010-09-02 | Lupin Limited | A process for the preparation of ranolazine |
WO2010137040A2 (en) | 2009-05-28 | 2010-12-02 | Lupin Limited | Novel pharmaceutical compositions of ranolazine |
BR112012006433A2 (pt) | 2009-09-25 | 2016-04-19 | Lupin Ltd | composição de libertação sustentada de ranolazina |
TWI508726B (zh) | 2009-12-21 | 2015-11-21 | Gilead Sciences Inc | 治療心房纖維性顫動之方法 |
TW201215392A (en) | 2010-06-16 | 2012-04-16 | Gilead Sciences Inc | Use of ranolazine for treating pulmonary hypertension |
NO3175985T3 (no) | 2011-07-01 | 2018-04-28 | ||
WO2013043925A1 (en) | 2011-09-21 | 2013-03-28 | Gilead Sciences, Inc. | Sodium channel blockers reduce glucagon secretion |
CN103570645A (zh) * | 2012-08-01 | 2014-02-12 | 上海迪赛诺化学制药有限公司 | 一种制备n-(2,6-二甲基苯基)-2-(1-哌嗪基)乙酰胺的方法 |
EP3782992A1 (en) | 2015-03-10 | 2021-02-24 | Unichem Laboratories Limited | Novel process for the preparation of ranolazine |
TW201717919A (zh) | 2015-07-02 | 2017-06-01 | 國際藥品股份公司 | 雷諾多重壓縮錠劑 |
WO2018001582A1 (en) | 2016-06-30 | 2018-01-04 | Interquim, S.A. | Ranolazine multiple compressed tablets |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3360529A (en) * | 1962-01-29 | 1967-12-26 | Smith Kline French Lab | Guanidinoalkylbenzodioxan derivatives |
US3829441A (en) * | 1962-01-29 | 1974-08-13 | Smith Kline French Lab | Guanidinoalkylbenzodioxan derivatives |
US3496183A (en) * | 1964-11-19 | 1970-02-17 | Egyt Gyogyszervegyeszeti Gyar | Beta-guanidino-ethyl-piperazine derivatives |
DE1795362A1 (de) * | 1968-09-19 | 1972-01-05 | Boehringer Mannheim Gmbh | Basische AEther und Verfahren zur Herstellung derselben |
DE1795375A1 (de) * | 1968-09-21 | 1972-01-05 | Boehringer Mannheim Gmbh | Basische AEther und Verfahren zur Herstellung derselben |
FR2154493B1 (no) * | 1971-09-13 | 1975-10-31 | Kali Chemie Ag | |
GB1332008A (en) * | 1971-09-28 | 1973-10-03 | Pfizer Ltd | Piperazine derivatives their preparation and pharmaceutical compositions containing them |
GB1374366A (en) * | 1972-07-21 | 1974-11-20 | Science Union & Cie | Propanol derivatives and a process for their preparation |
GB1425559A (en) * | 1972-09-01 | 1976-02-18 | Wyeth John & Brother Ltd | Pyridine tetrahydropyridine and piperidine derivatives |
GB1411531A (en) * | 1972-10-24 | 1975-10-29 | Lafon Labor | Amino derivatives of 1,4-benzodioxan |
US3953448A (en) * | 1972-12-07 | 1976-04-27 | Delmar Chemicals Limited | Piperazino-anilido compounds |
FR2267104A1 (en) * | 1974-04-12 | 1975-11-07 | Ferlux Labo Sa | Hypotensive and antiarrhythmic piperazines - 1-(3-phenoxy-2-hydroxy propyl)-4-substd. piperazines |
FR2310763A1 (fr) * | 1975-05-13 | 1976-12-10 | Buzas Andre | Derives 1,4-disubstitues de la piperazine, leur procede de preparation et leurs applications |
US4335126A (en) * | 1977-03-10 | 1982-06-15 | Degussa Aktiengesellschaft | 1-[3-(3,4,5-Trimethoxyphenoxy)-2-hydroxy-propyl]-4-aryl-piperazine-derivatives having pharmaceutical activity |
FR2387971A1 (fr) * | 1977-04-19 | 1978-11-17 | Delalande Sa | Nouvelles trimethoxy cinnamoyles piperazines, leur procede de preparation et leur application en therapeutique |
FR2462432A2 (fr) * | 1979-08-03 | 1981-02-13 | Delalande Sa | Nouveaux derives de la 3,4,5 trimethoxy cinnamoyle piperazine, leur procede de preparation et leur application en therapeutique |
FR2456738A2 (fr) * | 1978-04-10 | 1980-12-12 | Delalande Sa | Nouvelles cinnamoyles piperazines et homopiperazines, leur procede de preparation et leur application en therapeutique |
JPS6042795B2 (ja) * | 1978-10-23 | 1985-09-25 | 日本新薬株式会社 | カルバモイルピペラジン誘導体 |
EP0025111B1 (en) * | 1979-08-10 | 1984-07-25 | Sandoz Ag | 3-aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them |
DE2941597A1 (de) * | 1979-10-13 | 1981-04-23 | Basf Ag, 6700 Ludwigshafen | Piperidinderivate von 4,5-dialkyl-3-hydroxy-pyrrol-2-carbonsaeureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen |
GR71991B (no) * | 1980-01-21 | 1983-08-26 | Delalande Sa | |
DE3005287A1 (de) * | 1980-02-13 | 1981-08-20 | Basf Ag, 6700 Ludwigshafen | Phenylpiperazinderivate von 1,3,4-oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel |
US4302469A (en) * | 1980-09-10 | 1981-11-24 | Syntex (U.S.A.) Inc. | 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles useful as antidepressants |
US4684651A (en) * | 1981-03-17 | 1987-08-04 | Mitsubishi Chemical Industries Limited | Alkylenedioxybenzene and acid addition salts thereof useful as hypotensives |
US4766125A (en) * | 1981-06-23 | 1988-08-23 | Janssen Pharmaceutica N.V. | N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia |
US4374837A (en) * | 1981-07-31 | 1983-02-22 | Laroche Navarron, S.A. | Piperazine derivatives of theobromine |
US4353901A (en) * | 1981-10-19 | 1982-10-12 | Syntex (U.S.A.) Inc. | 9-(1,4-Benzodioxan-2-ylalkyl and hydroxyalkyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-ones |
-
1983
- 1983-05-18 US US06/495,904 patent/US4567264A/en not_active Expired - Lifetime
-
1984
- 1984-05-16 NO NO841968A patent/NO163618C/no not_active IP Right Cessation
- 1984-05-17 CA CA000454628A patent/CA1256874A/en not_active Expired
- 1984-05-17 IL IL71863A patent/IL71863A/xx not_active IP Right Cessation
- 1984-05-17 JP JP59097630A patent/JPS59219271A/ja active Granted
- 1984-05-17 SG SG598/89A patent/SG25086G/en unknown
- 1984-05-17 PL PL1984247722A patent/PL142760B1/pl unknown
- 1984-05-17 PH PH30692A patent/PH20016A/en unknown
- 1984-05-17 DE DE8484105643T patent/DE3468215D1/de not_active Expired
- 1984-05-17 ZA ZA843746A patent/ZA843746B/xx unknown
- 1984-05-17 HU HU841902A patent/HU192404B/hu unknown
- 1984-05-17 AT AT84105643T patent/ATE31533T1/de not_active IP Right Cessation
- 1984-05-17 CS CS843680A patent/CS246080B2/cs unknown
- 1984-05-17 IE IE1224/84A patent/IE57487B1/en not_active IP Right Cessation
- 1984-05-17 KR KR1019840002696A patent/KR890000020B1/ko not_active IP Right Cessation
- 1984-05-17 ES ES532565A patent/ES532565A0/es active Granted
- 1984-05-17 DK DK248384A patent/DK168535B1/da not_active IP Right Cessation
- 1984-05-17 FI FI841989A patent/FI78479C/fi not_active IP Right Cessation
- 1984-05-17 EP EP84105643A patent/EP0126449B1/en not_active Expired
- 1984-05-17 AU AU28346/84A patent/AU566489B2/en not_active Expired
- 1984-05-17 NZ NZ208188A patent/NZ208188A/en unknown
- 1984-05-17 PL PL1984252856A patent/PL143558B1/pl unknown
- 1984-05-17 PT PT78604A patent/PT78604B/pt unknown
- 1984-05-17 RU SU843741049A patent/RU2071471C1/ru active
-
1989
- 1989-11-16 HK HK919/89A patent/HK91989A/xx not_active IP Right Cessation
-
1991
- 1991-11-12 RU SU915001933A patent/RU2083570C1/ru active
-
1992
- 1992-06-18 MX MX9203001A patent/MX9203001A/es unknown
-
1997
- 1997-05-05 BR BR1100474-6A patent/BR1100474A/pt active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO163618C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aryloksy- og aryltio-hydroksypropyl-piperazin-acetanilider. | |
FI893632A0 (fi) | Foereningar. | |
NO159593C (no) | Analogifremgangsm te for fremstilling av terapeutisk virksomme dihydropyridinderivater. | |
NO903851D0 (no) | Fremgangsmaate for fremstilling av n-substituerte-4-pyrimidinaminer og -pyrimidindiaminer, og deres anvendelse som medikamenter. | |
KR950005817A (ko) | 5원환을 갖는 벤조-융합된 헤테로사이클릭 화합물, 이의 제조방법, 약제로서의 이의 용도, 진단제로서의 이의 용도 및 이를 함유하는 약제 | |
NO166126C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater. | |
NO173139C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-aminopyrimidinonderivater | |
NO874834D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridinoner. | |
NO163568C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater. | |
NO157377C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazodiazepiner. | |
ZA89389B (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia | |
NO833900L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive naftalenderivater | |
NO171366C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(3-alkyloksy-4-piperidinyl)benzamider | |
DK248886D0 (da) | Spiro-imidazolidin-forbindelser og farmaceutiske praeparater indeholdende disse | |
SE8105689L (sv) | Terapeutiska medel | |
EP0302757A3 (en) | Anti-emetic serotonin depleting agents | |
NO803862L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylaminoimidazolin-derivater | |
ES8104265A1 (es) | Un procedimiento para la preparacion de nuevas bencenosulfi-namidas | |
EA199700299A1 (ru) | Азольные соединения с противогрибковой (антимикозной) активностью, применяемые для лечения людей и в ветеринарии | |
NO170414C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-tienyloksyeddiksyrederivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |